The present disclosure provides a new medicament for treating for multiple sclerosis. More particularly, provided herein is the use of (-) 5-((((trans)-2-(4-(benzyloxy)phenyl)cyclopropyl)amino)methyl)-1,3,4-oxadiazol-2-amine, or a pharmaceutically acceptable salt or solvate thereof for treating multiple sclerosis in a patient.
METHODS OF TREATING MULTIPLE SCLEROSIS